REDRESS
RElated haplo-DonoR haematopoietic stEm cell transplantation for adults with Severe Sickle cell disease
Sponsor
King's College Hospital NHS Foundation Trust
Description
This study is run by a multi-disciplinary team of doctors, nurses, scientists, statisticians, managers and administrators.
The purpose of the REDRESS trial is to determine whether stem cell transplant using haplo-identical related donors is safe, effective, and cost worthy in treating adults with sickle cell disorder compared with the standard of care treatment.
Stem cell transplant from a haplo-identical donor is not currently available for adults on the NHS and can only be accessed through this research study.
Site name
Multisite
Site PI
Chief Investigator: Dr V. Potter
Start date
23/02/2023
End date
30/06/2027
